AI-generated summary
The authors studied how low-dose photodynamic therapy affects human mesenchymal stromal cells grown in vitro, a model of tumor stroma. They report that the treatment increased reactive oxygen species, reduced cell motility, and raised secretion of several proangiogenic factors, improving the cells' ability to promote angiogenesis. The findings come from an in vitro study, so the clinical relevance is unclear.
- Who or what was studied
- Human mesenchymal stromal cells studied in an in vitro model
- Limits stated in the abstract
- The study is an in vitro cell model, so its findings may not translate directly to tumors in patients.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photodynamic therapy, Dose, Reactive oxygen species, Angiogenesis. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.